BS and MS, Morehead State University, 1994-2001
PhD, Marshall University, 2001-2007
My research involves the study of angiotensin converting enzyme 2 (ACE2) and the effects of ACE2 deficiency in cardiovascular disease, obesity, and inflammation. ACE2 catabolizes angiotensin II to form the vasoprotective peptide, angiotensin-(1-7). Recent work has shown that chronic angiotensin-(1-7) infusion by osmotic pump, lowers angiotensin II-induced atherosclerosis. Current projects look to evaluate the role of ACE2 in the immune system and to understand the role of ACE2 in macrophages.
F32HL095281, ACE2 in Hypercholesterolemia and Angiotensin II-Induced Vascular Disease (Ruth L. Kirschstein National Research Service Award, 2009-2012)